Deborah S Mortensen

14PUBLICATIONS
60CO-AUTHORS
Biologically active moleculesMolecular targetsHaematological tumoursProteins and peptidesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 10, 2026
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365.

|Jun 29, 2026
NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma.

|Feb 11, 2026
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma.

Deborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas

|Dec 15, 2025
Recent advances in glutarimide chemistry for cereblon-mediated targeted protein degradation: developments in synthesis and diversification.

Xiaochu Ba, Mahzad Dehghany, Deborah S Mortensen

|Oct 07, 2025
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760.

Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

Pageof 3

Frequent Collaborators

4 joint publications

Natalie Holmberg-Douglas

4 joint publications

Gody Khambatta

3 joint publications

Joshua Hansen

3 joint publications

Jinyi Zhu